GB0912493D0 - Preparation of bile acids and intermediates thereof - Google Patents

Preparation of bile acids and intermediates thereof

Info

Publication number
GB0912493D0
GB0912493D0 GBGB0912493.4A GB0912493A GB0912493D0 GB 0912493 D0 GB0912493 D0 GB 0912493D0 GB 0912493 A GB0912493 A GB 0912493A GB 0912493 D0 GB0912493 D0 GB 0912493D0
Authority
GB
United Kingdom
Prior art keywords
intermediates
preparation
bile acids
bile
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0912493.4A
Other versions
GB2460350B (en
GB2460350A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kythera Biopharmaceuticals LLC
Original Assignee
Kythera Biopharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kythera Biopharmaceuticals LLC filed Critical Kythera Biopharmaceuticals LLC
Priority to GB0912493A priority Critical patent/GB2460350B/en
Priority claimed from GB0807615A external-priority patent/GB2452358C/en
Publication of GB0912493D0 publication Critical patent/GB0912493D0/en
Publication of GB2460350A publication Critical patent/GB2460350A/en
Application granted granted Critical
Publication of GB2460350B publication Critical patent/GB2460350B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
GB0912493A 2008-04-25 2008-04-25 Intermediates for the preparation of bile acids Expired - Fee Related GB2460350B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0912493A GB2460350B (en) 2008-04-25 2008-04-25 Intermediates for the preparation of bile acids

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0807615A GB2452358C (en) 2008-04-25 2008-04-25 Preparation of bile acids.
GB0912493A GB2460350B (en) 2008-04-25 2008-04-25 Intermediates for the preparation of bile acids

Publications (3)

Publication Number Publication Date
GB0912493D0 true GB0912493D0 (en) 2009-08-26
GB2460350A GB2460350A (en) 2009-12-02
GB2460350B GB2460350B (en) 2011-04-06

Family

ID=41058157

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0912493A Expired - Fee Related GB2460350B (en) 2008-04-25 2008-04-25 Intermediates for the preparation of bile acids

Country Status (1)

Country Link
GB (1) GB2460350B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115611961A (en) * 2022-10-18 2023-01-17 湖南科瑞生物制药股份有限公司 Cholic acid intermediate A2 and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
AU698834B2 (en) * 1993-05-24 1998-11-12 Purdue Pharma Ltd. Methods and compositions for inducing sleep
AU3967297A (en) * 1996-08-01 1998-02-25 Cocensys, Inc. Use of gaba and nmda receptor ligands for the treatment of migraine headache
KR100527411B1 (en) * 2003-08-23 2005-11-09 한국과학기술원 Noble Monomers, Polymers and Photoresist Materials with 7,7-Dimethyloxepan-2-one Group and Method for Patterning

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115611961A (en) * 2022-10-18 2023-01-17 湖南科瑞生物制药股份有限公司 Cholic acid intermediate A2 and preparation method thereof
CN115611961B (en) * 2022-10-18 2024-02-13 湖南科瑞生物制药股份有限公司 Cholic acid intermediate A2 and preparation method thereof

Also Published As

Publication number Publication date
GB2460350B (en) 2011-04-06
GB2460350A (en) 2009-12-02

Similar Documents

Publication Publication Date Title
GB2452358B (en) Preparation of bile acids
IL206664A0 (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
IL199945A0 (en) 23-substituted bile acids as tgr5 modulators and methods of use thereof
IL209136A0 (en) Compositions of peptides and processes of preparation thereof
EP2434888A4 (en) Ketal esters of anhydropentitols and uses thereof
IL202664A (en) Processes for the preparation of 3-dihalomethyl-1-methyl-1h- pyrazole-4-carbaldehyde and intermediates
EP2444398A4 (en) Novel intermediates of voriconazole and preparation method of voriconazole using the same
IL210835A0 (en) Processes for the preparation of 4-oxo-octahydro-indole-1-carboxylic acid methyl ester and derivatives thereof
EP2429982A4 (en) Methods of making lubiprostone and intermediates thereof
ZA201102207B (en) Cinnamandehyde-allicin compositions and their method of use
SI2189442T1 (en) Process and intermediates for the preparation of aliskiren
IL217097A0 (en) Process for the preparation of 1-benzyl-3-hydroxymethyl- 1h- indazole and its derivatives and required magnesium intermediates
GB0912493D0 (en) Preparation of bile acids and intermediates thereof
IL219316A0 (en) Processes for the preparation of 5-lipooxygenase activating protein inhibitors and their intermediates
HK1137178A (en) Preparation of bile acids and intermediates thereof
EG27000A (en) Process for the preparation of ibodutant (MEN15596) and related intermediates
HK1172610A (en) Processes for the preparation of lacosamide and intermediates thereof
GB0920931D0 (en) Bracket assembly and method of use thereof
GB0910796D0 (en) Bracket assembly and method of use thereof
GB0820804D0 (en) Perinropril composition and method of use thereof
PL386930A1 (en) New S-substituted 2-thiorotic acids and the method of obtaining them
GB0808285D0 (en) Preparation of methylenedioxybenzene and derivatives thereof

Legal Events

Date Code Title Description
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1137178

Country of ref document: HK

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1137178

Country of ref document: HK

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20220425